Advagene Biopharma Co., Ltd. (TPEX:6709)
24.90
+1.10 (4.62%)
Aug 4, 2026, 1:54 PM CST
16.90% (1Y)
| Market Cap | 1.40B +10.3% |
| Revenue (ttm) | n/a |
| Net Income | -68.29M |
| EPS | -1.15 |
| Shares Out | 59.38M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 58,262 |
| Open | 23.80 |
| Previous Close | 23.80 |
| Day's Range | 23.80 - 25.90 |
| 52-Week Range | 21.50 - 41.00 |
| Beta | 0.62 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 13, 2026 |